IL314035A - Bicyclic phthalazine-1(2H)-one derivatives and related uses - Google Patents

Bicyclic phthalazine-1(2H)-one derivatives and related uses

Info

Publication number
IL314035A
IL314035A IL314035A IL31403524A IL314035A IL 314035 A IL314035 A IL 314035A IL 314035 A IL314035 A IL 314035A IL 31403524 A IL31403524 A IL 31403524A IL 314035 A IL314035 A IL 314035A
Authority
IL
Israel
Prior art keywords
phthalazin
bicyclic
derivatives
related uses
bicyclic phthalazin
Prior art date
Application number
IL314035A
Other languages
English (en)
Hebrew (he)
Inventor
Mark G Bock
David Harrison
Jane E Scanlon
Original Assignee
Nodthera Ltd
Mark G Bock
David Harrison
Jane E Scanlon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nodthera Ltd, Mark G Bock, David Harrison, Jane E Scanlon filed Critical Nodthera Ltd
Publication of IL314035A publication Critical patent/IL314035A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL314035A 2022-01-07 2023-01-06 Bicyclic phthalazine-1(2H)-one derivatives and related uses IL314035A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263297444P 2022-01-07 2022-01-07
PCT/US2023/010314 WO2023133271A1 (en) 2022-01-07 2023-01-06 Bicyclic phthalazin-1(2h)-one derivatives and related uses

Publications (1)

Publication Number Publication Date
IL314035A true IL314035A (en) 2024-09-01

Family

ID=85239129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314035A IL314035A (en) 2022-01-07 2023-01-06 Bicyclic phthalazine-1(2H)-one derivatives and related uses

Country Status (10)

Country Link
US (1) US20250066369A1 (enExample)
EP (1) EP4460505A1 (enExample)
JP (1) JP2025504374A (enExample)
KR (1) KR20240145992A (enExample)
CN (1) CN118922421A (enExample)
AU (1) AU2023205048A1 (enExample)
CA (1) CA3247232A1 (enExample)
IL (1) IL314035A (enExample)
MX (1) MX2024008477A (enExample)
WO (1) WO2023133271A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025153532A1 (en) * 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
RU2364597C1 (ru) * 2007-12-14 2009-08-20 Андрей Александрович Иващенко ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
US20240043450A1 (en) * 2020-09-24 2024-02-08 Janssen Pharmaceutica Nv New compound

Also Published As

Publication number Publication date
CN118922421A (zh) 2024-11-08
KR20240145992A (ko) 2024-10-07
MX2024008477A (es) 2024-08-30
JP2025504374A (ja) 2025-02-12
WO2023133271A1 (en) 2023-07-13
US20250066369A1 (en) 2025-02-27
EP4460505A1 (en) 2024-11-13
CA3247232A1 (en) 2023-07-13
AU2023205048A1 (en) 2024-07-18

Similar Documents

Publication Publication Date Title
IL291181A (en) Pyridazine-3(h2)-one derivatives from sister-azoles
IL165173A0 (en) Pyridazin-3(2H)-one derivatives as pde4 inhibitors
ZA200700634B (en) Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
CA221576S (en) Foldable bathtub
PT1575926E (pt) Novos derivados de piridazin-3(2h)-ona
DE602005025478D1 (de) Pyridazin-3(2h)-on derivate und ihre verwendung als pde4 inhibitoren
SG11202106635WA (en) Combination of antibody-drug conjugate and kinase inhibitor
IL226870A0 (en) Quinazolinone derivatives modified at position 7, 6 or 8, their compositions and methods of their use
IL314035A (en) Bicyclic phthalazine-1(2H)-one derivatives and related uses
IL178908A0 (en) Benzotriazine inhibitors of kinases
GB2440188B (en) Amplifier Circuits, Methods of Starting and Stopping Amplifier Circuits
IL300107A (en) HSD17B13 quinazolinone inhibitors and uses thereof
LT4355749T (lt) Tricikliniai parp1 inhibitoriai ir jų panaudojimo būdai
IL320829A (en) PARP1 inhibitors and their uses
IL273882A (en) Double-sided and indexable cutting tool with a narrow middle part for high-feed drilling and milling
IS7435A (is) Indólamíðafleiður sem búa yfir tálmavirkni gegn glýkógenfosfórýlasa
ZA201104785B (en) Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one,preparation and therapeutic use thereof
IL299732A (en) Macrocycles and their use
IL219934A0 (en) Quinazolin-4(3a)-one derivatives and methods of use thereof
HK40118512A (en) Bicyclic phthalazin-1(2h)-one derivatives and related uses
GB2615605B (en) Plumbing fitting accessory
IL310498A (en) (3-pyridyl)-quinazoline
IL308488A (en) CD40L antagonist and its uses in the treatment of lupus nephritis
EP4142874A4 (en) PYRIMIDIN-4(3H)-ONE DERIVATIVES AS TRPV4 ANTAGONISTS
AU2003261612A8 (en) Derivatives of triptolide having high immunosuppressive effect and high water solubility, and uses thereof